Pharma — Maj 2023
-
Astellas Pharma To Acquire Iveric Bio In $5.9 Bln Deal https://www.proinvestor.com/investornyt/976671/astellas-pharma-to-acquire-iveric-bio-in-59-bln-deal
-
Teva Recalls FENTANYL Buccal Tablets CII https://www.proinvestor.com/investornyt/976686/teva-recalls-fentanyl-buccal-tablets-cii
-
Jyske Bank hæver anbefaling for Rockwool forud for regnskab
https://www.proinvestor.com/investornyt/977328/jyske-bank-haever-anbefaling-for-rockwool-forud-for-regnskab -
Lundbeck får løftet kursmålet hos norsk finanshus https://www.proinvestor.com/investornyt/977330/lundbeck-far-loftet-kursmalet-hos-norsk-finanshus
-
FDA Approves First Drug For Anemia In Cats With CKD https://www.proinvestor.com/investornyt/977333/fda-approves-first-drug-for-anemia-in-cats-with-ckd
-
Pfizer rammer over estimater og fastholder forventninger https://www.proinvestor.com/investornyt/977436/pfizer-rammer-over-estimater-og-fastholder-forventninger
-
Lilly's donanemab slows cognitive,
functional decline in key Alzheimer's study https://firstwordpharma.com/story/5734975 -
Eli Lilly tordner i vejret oven på succesrigt alzheimers-studie
https://www.proinvestor.com/investornyt/978178/eli-lilly-tordner-i-vejret-oven-pa-succesrigt-alzheimers-studie -
Kort video - Novo Nordisk ' Anavex ' Eli Lilly ' Biogen ' Brain+ -
Helge Larsen kigger bl.a. på regnskab fra Novo Nordisk og på Anavex og udviklingen inden for medicin mod alzheimers og demens. https://www.proinvestor.com/boards/112459/
-
Mioklubben i dag Du kan i dagens afsnit høre mere om blandt andre Bakkafrost, Mowi, Grieg seafood. Nordic Halibut, Anavex, Genmab, Brain+, INSW, Norden, Pfizer, Novo Nordisk, Siemens Energy, Mercedes Benz Group, Ambu, Mærsk og Biogen.
Podcast: https://www.euroinvestor.dk/podcast/millionaerklubben-der-er-penge-i-sundhed
-
ALK-ABELLO - Regnskab for Q1 2023
https://www.proinvestor.com/boards/112521 -
ALK bekræfter toplinjevækst - har uændret bundlinje https://www.proinvestor.com/investornyt/981572/alk-bekraefter-toplinjevaekst-har-uaendret-bundlinje
-
Alk: Kan kvartalsregnskabet formilde nervøse investorer
https://www.proinvestor.com/boards/112527 -
ALK's topchef om afdæmpet tabletsalg: Vi har jo ikke trykket på en panikknap https://www.proinvestor.com/investornyt/981634/alks-topchef-om-afdaempet-tabletsalg-vi-har-jo-ikke-trykket-pa-en-panikknap
-
Lundbeck overrasker positivt i første kvartal - Vyepti fortsætter frem
https://www.proinvestor.com/investornyt/982499/lundbeck-overrasker-positivt-i-forste-kvartal-vyepti-fortsaetter-frem -
Lundbeck/Sydbank: Styrer mod prognosetoppen med stærkt første kvartal https://www.proinvestor.com/investornyt/982638/lundbeck-sydbank-styrer-mod-prognosetoppen-med-staerkt-forste-kvartal
-
Lundbeck (+1,4%, 35,74) har torsdag morgen fået grønt lys fra de amerikanske sundhedsmyndigheder til markedsføring af Brexpiprazol som behandling af agitation - eller vredesudbrud - hos Alzheimers-patienter.
-
"Enorm fornøjelse" for Lundbecks direktør med vigtig godkendelse https://www.proinvestor.com/investornyt/983406/enorm-fornojelse-for-lundbecks-direktor-med-vigtig-godkendelse
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind